MedPath

The Effect of Microneedle Pretreatment on Topical Anesthesia

Not Applicable
Completed
Conditions
Pain
Interventions
Device: Microneedle Roller
Device: Sham microneedle Roller
Registration Number
NCT02596750
Lead Sponsor
University of California, Davis
Brief Summary

This study evaluates the role of microneedle pretreatment in the speed at which anesthesia develops after application of topical 4% lidocaine.

Detailed Description

This study evaluates whether the time to anesthesia with topical 4% lidocaine can be accelerated with the use of microneedle pretreatment. The study will evaluate the anesthesia as a randomized split-body study where each subject serves as their own control. The study will be performed on the volar forearm. Prior to application of the topical 4% lidocaine, one arm will be exposed to a microneedle pretreatment on a microneedle roller and the other arm will be exposed to sham microneedle treatment that will consist of a flat roller with no microneedles. Then pain will be assessed with the use of a spring loaded needle lancet that will be applied at 2 min, 5 min, 10 min, and 30 minutes after treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
21
Inclusion Criteria
  • Healthy volunteers
Read More
Exclusion Criteria
  • Allergy to lidocaine
  • Smokers
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Microneedle PretreatmentMicroneedle RollerOne ventral forearm is randomized to receive pretreatment with microneedle rollers that are 200 micrometers in length (Clinical Resolution Laboratories, Inc.). Then topical 4% lidocaine is applied and pain in assessed after a pain stimulus at the 2 min, 4 min, 10 min, and 30 min time points.
Sham Microneedle PretreatmentSham microneedle RollerOne ventral forearm is randomized to receive pretreatment with sham microneedle rollers (flat roller without any microneedles) that are 200 micrometers in length (Clinical Resolution Laboratories, Inc.). Then topical 4% lidocaine is applied and pain in assessed after a pain stimulus at the 2 min, 4 min, 10 min, and 30 min time points.
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale Pain30 min

100 mm Visual Analog Scale pain grading. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of California Davis

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath